Literature DB >> 4744861

Antineoplastic activity of lipid-soluble dialkyl esters of methotrexate.

D G Johns, D Farquhar, B A Chabner, M K Wolpert, R H Adamson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4744861     DOI: 10.1007/bf01946745

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  5 in total

Review 1.  TECHNIQUES FOR STUDY OF RESISTANCE TO FOLIC ACID ANTAGONISTS.

Authors:  J R BERTINO; G A FISCHER
Journal:  Methods Med Res       Date:  1964

2.  PURIFICATION AND PROPERTIES OF DIHYDROFOLATE REDUCTASE FROM EHRLICH ASCITES CARCINOMA CELLS.

Authors:  J R BERTINO; J P PERKINS; D G JOHNS
Journal:  Biochemistry       Date:  1965-05       Impact factor: 3.162

Review 3.  Folate antagonists.

Authors:  J R Bertino; D G Johns
Journal:  Annu Rev Med       Date:  1967       Impact factor: 13.739

4.  Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.

Authors:  D G Johns; D Farquhar; M K Wolpert; B A Chabner; T L Loo
Journal:  Drug Metab Dispos       Date:  1973 May-Jun       Impact factor: 3.922

5.  Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.

Authors:  G L Neil; H H Buskirk; T E Moxley; R C Manak; S L Kuentzel; B K Bhuyan
Journal:  Biochem Pharmacol       Date:  1971-12       Impact factor: 5.858

  5 in total
  2 in total

1.  Pharmacologic studies on the dibutyl and gamma-monobutyl esters of methotrexate in the rhesus monkey.

Authors:  A Rosowsky; H T Abelson; G P Beardsley; W D Ensminger; D W Kufe; G Steele; E J Modest
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

2.  Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia.

Authors:  A Ramu; M Fridkin; R Steinherz
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.